Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;28(6):647-655.
doi: 10.1111/exd.13677. Epub 2018 Jun 28.

The convergence theory for vitiligo: A reappraisal

Affiliations
Review

The convergence theory for vitiligo: A reappraisal

Roopal V Kundu et al. Exp Dermatol. 2019 Jun.

Abstract

Vitiligo is characterized by progressive loss of skin pigmentation. The search for aetiologic factors has led to the biochemical, the neurologic and the autoimmune theory. The convergence theory was then proposed several years ago to incorporate existing theories of vitiligo development into a single overview of vitiligo aetiology. The viewpoint that vitiligo is not caused only by predisposing mutations, or only by melanocytes responding to chemical/radiation exposure, or only by hyperreactive T cells, but rather results from a combination of aetiologic factors that impact melanocyte viability, has certainly stood the test of time. New findings have since informed the description of progressive depigmentation. Understanding the relative importance of such aetiologic factors combined with a careful selection of the most targetable pathways will continue to drive the next phase in vitiligo research: the development of effective therapeutics. In that arena, it is likewise important to acknowledge that pathways affected in some patients may not be altered in others. Taken together, the convergence theory continues to provide a comprehensive viewpoint of vitiligo aetiology. The theory serves to intertwine aetiologic pathways and will help to define pathways amenable to disease intervention in individual patients.

Keywords: autoimmune; depigmentation; melanocyte; vitiligo aetiology.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors have declared no conflicting interests.

Figures

FIGURE 1
FIGURE 1
A, Vitiligo aetiology explored between 1990 and 2015. When the convergence theory was first proposed, it united emerging concepts surrounding vitiligo etiopathology. A PubMed search was performed using the terms “vitiligo” plus either “immune,” “genetic,” “oxidative stress” or “neuronal” and the year of publication. When separated into these four mainline theories to explain vitiligo development, the number of publications addressing each between 1990 and 2015 indicates shifts in vitiligo research over time, with the attention shifting towards genetic and immune factors by the mid-nineties and more recently, renewed attention for oxidative stress. B, Increase in vitiligo publications over time. A PubMed search was performed using the year of publication, with or without the term “vitiligo.” The proportion of publications relating to vitiligo has increased 3-fold over the 25-year period of analysis
FIGURE 2
FIGURE 2
Publications related to vitiligo treatment. A PubMed search was performed with the year of publication combined with ‘vitiligo’ plus the terms shown in the legend, with the exception of the black line. Here, the year of publication was combined with the search terms ‘vitiligo treatment’ and the total number was divided by five, as represented in the graph. Not represented in the graph are recent developments including JAK inhibitors and Tregs.

References

    1. Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK. J. Invest. Dermatol. 1993;100:816. - PubMed
    1. Cieścińska C, Pawlak-Osińska K, Marzec M, Kaźmierczak K, Malukiewicz G, Drewa G, Czajkowski R. Acta Dermatovenerol. Croat. 2016;24:20. - PubMed
    1. Anbar TS, El-Badry MM, McGrath JA, Abdel-Azim ES. Br. J. Dermatol. 2015;172:406. - PubMed
    1. Gan EY, Cario-André M, Pain C, Goussot JF, Taïeb A, Seneschal J, Ezzedine K. J. Am. Acad. Dermatol. 2016;74:1178. - PubMed
    1. Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W. Exp. Dermatol. 1993;2:145. - PubMed

Publication types